David O'Toole
About David O'Toole
David O'Toole is a seasoned financial executive with extensive experience in the biopharmaceutical sector, currently serving as the Chief Financial Officer.
David O'Toole - Chief Financial Officer
David O'Toole currently serves as the Chief Financial Officer, bringing extensive experience from multiple roles in the life sciences sector. His executive roles have included CFO positions at Opiant Pharmaceuticals and Soleno Therapeutics. O'Toole's robust financial acumen and industry know-how position him as a valuable asset to any organization he serves.
David O'Toole's Career in Public Accounting
David O'Toole has significant experience in public accounting, having spent over 20 years in the field. Notably, he dedicated 16 years of his career to Deloitte & Touche, one of the 'Big Four' accounting firms. His extensive background in public accounting has equipped him with a strong foundation in financial principles and practices.
David O'Toole's Education and Certifications
David O'Toole holds a Bachelor of Science in accounting from the University of Arizona. In addition to his academic credentials, he is a Certified Public Accountant (CPA), although he currently holds a non-active status. His education and certification underpin his expertise in financial management and accounting.
CFO Experience at Life Sciences Companies
Throughout his career, David O'Toole has served as Chief Financial Officer for three publicly traded life sciences companies. His tenure includes pivotal roles at Opiant Pharmaceuticals, where he contributed to developing treatments for addiction and overdose, and at Soleno Therapeutics, where he focused on therapeutics for rare diseases. His experience in this sector highlights his ability to handle complex financial portfolios within the biopharmaceutical industry.